The defendants are drugmakers Eli Lilly, Novo Nordisk and Sanofi-Aventis; PBM Evernorth Health; Express Scripts and its subsidiaries Medco Health Solutions and Esi Mail Pharmacy Services; CVS Health and CVS Caremark; and UnitedHealth Group and its businesses Optum, OptumRx and OptumInsight.
The city filed the suit July 24.
“Diabetics need insulin to stay alive,” Cleveland officials said in a news release. “The defendants exploit this reality to guarantee their price-fixing scheme, making insulin unaffordable to individuals and resulting in exorbitant costs for prescription benefit sponsors like the city of Cleveland.”
A CVS spokesperson called the case “baseless” and an Eli Lilly spokesperson said it was “meritless.” Evernorth did not respond to Becker’s request for comment.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
